Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial (Q84511909)
Jump to navigation
Jump to search
scientific article published on 01 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial |
scientific article published on 01 October 2011 |
Statements
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial (English)
V Lukashevich
A Schweizer
Q Shao
P-H Groop
1 October 2011